Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Melanoma 18Carcinoma, Non-Small-Cell Lung 11Squamous Cell Carcinoma of Head and Neck 7Neoplasms 7Carcinoma, Renal Cell 7Stomach Neoplasms 5Pancreatic Neoplasms 5Breast Neoplasms 5Small Cell Lung Carcinoma 4Ovarian Neoplasms 4Esophageal Neoplasms 4Colorectal Neoplasms 4Carcinoma, Transitional Cell 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Salivary Gland Neoplasms 3Prostatic Neoplasms 3Neoplasm Metastasis 3Head and Neck Neoplasms 3Urinary Bladder Neoplasms 2Sarcoma, Kaposi 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Lung Neoplasms 2Esthesioneuroblastoma, Olfactory 2Colonic Neoplasms 2Chondrosarcoma 2Carcinoma, Merkel Cell 2Carcinoma, Hepatocellular 2

Interventions

Nivolumab 4pembrolizumab 2Ipilimumab 2fludarabine phosphate 1fludarabine 1durvalumab 1avelumab 1atezolizumab 1Interleukin-2 1Docetaxel 1Cyclophosphamide 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Turcot syndrome × Docetaxel × Dermatologic × Clear all
NCT03228667 2026-01-14

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

ImmunityBio, Inc.

Phase 2 Active not recruiting
40 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Microsatellite Instability, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡